A Phase II study of (153)Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma (Q37509952)
Jump to navigation
Jump to search
scientific article published on June 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | A Phase II study of (153)Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma |
scientific article published on June 2010 |
Statements
1 reference
A Phase II study of (153)Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma (English)
1 reference
David Dingli
1 reference
Angela Dispenzieri
1 reference
Martha Q Lacy
1 reference
Morie A Gertz
1 reference
Suzanne R Hayman
1 reference
Mark R Litzow
1 reference
Francis Buadi
1 reference
Shaji K Kumar
1 reference
Stephen M Ansell
1 reference
Dennis A Gastineau
1 reference
Ivana N Micallef
1 reference
Luis Porrata
1 reference
David J Inwards
1 reference
Michelle A Elliott
1 reference
Susan M Geyer
1 reference
Gregory A Wiseman
1 reference
Krista M Laumann
1 reference
Jake Allred
1 reference
Patrick B Johnston
1 reference
William J Hogan
1 reference
1 June 2010
1 reference
1 reference
409-413
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference